3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
3
Head & Neck
2
Gynecologic
2
Gastrointestinal
1
Dermatologic
1
Conditions
Melanoma
17
Lung Neoplasms
6
Head and Neck Neoplasms
6
Pancreatic Neoplasms
5
Neoplasms
5
Colorectal Neoplasms
5
Breast Neoplasms
5
Ovarian Neoplasms
4
Kidney Neoplasms
4
Waldenstrom Macroglobulinemia
3
Stomach Neoplasms
3
Skin Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Mycosis Fungoides
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Liver Neoplasms
3
Glioblastoma
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Sezary Syndrome
2
Sarcoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
pembrolizumab
8
Nivolumab
4
fludarabine
2
Cyclophosphamide
2
sonidegib
1
obinutuzumab
1
methyl 5-aminolevulinate
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
durvalumab
1
daromun
1
cabozantinib
1
avelumab
1
atezolizumab
1
advexin
1
Tomography, Optical Coherence
1
Therapeutics
1
Taxes
1
Specimen Handling
1
Radiotherapy
1
ProMune
1
Pemetrexed
1
Paclitaxel
1
Oncolytic Virotherapy
1
Mesna
1
Magnetic Resonance Spectroscopy
1
MAPRE1 protein, human
1
Lutetium-177
1
Interleukin-2
1
HhAntag691
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma
×
Drug Therapy
×
Dermatologic
×
Clear all
NCT00070642
2009-02-10
CPG 7909 Injection in Melanoma
Pfizer
Phase 2
Completed
184 enrolled